HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Shilong Wang Selected Research
Shilong Wang Research Topics
Disease
20
Neoplasms (Cancer)
09/2022 - 03/2010
3
Carcinoma (Carcinomatosis)
11/2017 - 10/2013
3
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2017 - 01/2016
2
Hepatocellular Carcinoma (Hepatoma)
10/2021 - 11/2019
2
Stomach Neoplasms (Stomach Cancer)
01/2021 - 01/2013
2
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
02/2020 - 11/2019
2
Parkinson Disease (Parkinson's Disease)
01/2020 - 02/2008
2
Osteosarcoma (Osteogenic Sarcoma)
01/2019 - 01/2014
2
Glioma (Gliomas)
07/2018 - 11/2016
2
Hypoxia (Hypoxemia)
11/2015 - 02/2014
1
Anemia
02/2022
1
Thyroid Neoplasms (Thyroid Cancer)
10/2021
1
Carcinogenesis
10/2021
1
Spinal Cord Injuries (Spinal Cord Injury)
01/2021
1
Hypoglycemia (Reactive Hypoglycemia)
10/2020
1
Perinatal Death
10/2020
1
Margins of Excision
01/2020
1
Fetal Growth Retardation (Intrauterine Growth Retardation)
01/2020
1
Unstable Angina
03/2019
1
Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
03/2019
1
Homozygous Familial Hypercholesterolemia
03/2019
1
Atherosclerotic Plaque (Atheroma)
03/2019
1
Teratoma (Teratoid Tumor)
01/2018
1
Uterine Cervical Neoplasms (Cancer of the Cervix)
12/2017
1
Neuroblastoma
11/2017
1
Coronary Artery Disease (Coronary Atherosclerosis)
11/2017
1
Neoplasm Metastasis (Metastasis)
11/2016
1
Breast Neoplasms (Breast Cancer)
10/2016
1
Thrombocytopenia (Thrombopenia)
01/2016
1
Leukopenia
01/2016
1
Alopecia (Baldness)
01/2016
1
Sepsis (Septicemia)
01/2015
1
Inflammation (Inflammations)
08/2014
Drug/Important Bio-Agent (IBA)
6
Pharmaceutical Preparations
IBA
01/2021 - 03/2010
6
Etoposide (VP 16)
FDA Link
Generic
01/2021 - 07/2013
6
Curcumin
IBA
12/2017 - 01/2012
4
hydroxide ion
IBA
07/2018 - 01/2016
3
Biological Products
IBA
09/2022 - 10/2016
3
Long Noncoding RNA
IBA
02/2020 - 11/2015
3
Hydroxides
IBA
01/2016 - 03/2010
2
Silicon Dioxide (Silica)
FDA Link
Generic
10/2021 - 10/2016
2
Proteins (Proteins, Gene)
FDA Link
01/2016 - 02/2014
2
Lipopolysaccharides
IBA
01/2015 - 08/2014
2
Lipid Nanoparticles
IBA
01/2015 - 01/2012
2
DNA (Deoxyribonucleic Acid)
IBA
01/2014 - 01/2011
1
Carbohydrates
IBA
02/2022
1
Antigens
IBA
02/2022
1
Phosphoric Monoester Hydrolases (Phosphatases)
IBA
10/2021
1
diphosphoric acid (pyrophosphoric acid)
IBA
10/2021
1
phosphohistidine
IBA
10/2021
1
Biocompatible Materials (Biomaterials)
IBA
01/2021
1
Graphite
IBA
01/2021
1
Liver Glycogen
IBA
10/2020
1
Glycogen
IBA
10/2020
1
Cannabinoid Receptors (Cannabinoid Receptor)
IBA
01/2020
1
AM 1241
IBA
01/2020
1
Sorafenib (BAY 43-9006)
FDA Link
11/2019
1
Peptidylprolyl Isomerase (Prolyl Isomerase)
IBA
11/2019
1
STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)
IBA
11/2019
1
Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))
IBA
11/2019
1
Glucose (Dextrose)
FDA Link
Generic
04/2019
1
Chlorides
IBA
04/2019
1
Enzymes
IBA
04/2019
1
Oxygen (Dioxygen)
IBA
04/2019
1
Peptides (Polypeptides)
IBA
04/2019
1
Reactive Oxygen Species (Oxygen Radicals)
IBA
04/2019
1
Hydrogels
IBA
04/2019
1
Singlet Oxygen
IBA
04/2019
1
Lipids
IBA
03/2019
1
Small Interfering RNA (siRNA)
IBA
01/2019
1
Catenins
IBA
01/2019
1
Alkaline Phosphatase
IBA
01/2018
1
tocophersolan
IBA
12/2017
1
UCON 50-HB-5100 (F127)
IBA
12/2017
1
Micelles
IBA
12/2017
1
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
11/2017
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
11/2017
1
Doxorubicin (Adriamycin)
FDA Link
Generic
11/2017
1
Bevacizumab (Avastin)
FDA Link
11/2017
1
Paxillin
IBA
11/2016
1
Solutions
IBA
10/2016
1
Calcium
IBA
10/2016
1
Folic Acid (Vitamin M)
FDA Link
Generic
10/2016
1
Biomarkers (Surrogate Marker)
IBA
10/2016
1
Drug Carriers
IBA
12/2015
1
Transforming Growth Factors (Transforming Growth Factor)
IBA
11/2015
1
Sirtuin 1
IBA
11/2015
1
Interleukins
IBA
01/2015
1
Eosine Yellowish-(YS) (Eosin)
IBA
01/2015
1
Hematoxylin (Haematoxylon)
IBA
01/2015
1
Firefly Luciferases
IBA
01/2015
Therapy/Procedure
13
Therapeutics
01/2021 - 01/2012
3
Drug Therapy (Chemotherapy)
01/2020 - 07/2018
2
Immunotherapy
10/2021 - 04/2019
1
Quantum Dots (Quantum Dot)
01/2021
1
Minimally Invasive Surgical Procedures
01/2020
1
Injections
04/2019
1
Percutaneous Coronary Intervention
03/2019
1
Photochemotherapy (Photodynamic Therapy)
01/2017
1
Intraperitoneal Injections
10/2016